Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • AYUSH

    AYUSH - Page 2

    732 complaints of misleading advertisements regarding herbal medicines: Minister informs Parliament

    732 complaints of misleading advertisements regarding herbal medicines: Minister informs Parliament

    Ruby Khatun Khatun12 Aug 2018 10:15 AM IST
    New Delhi: The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Rajya Sabha 732...
    Two-week training programme on herbal drugs starts at NIPER

    Two-week training programme on herbal drugs starts at NIPER

    Ruby Khatun Khatun9 Aug 2018 10:00 AM IST
    Mohali: A two-week-long intensive training programme on trends and challenges in regulation and standardization of herbal drugs and formulations...
    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ruby Khatun Khatun5 Aug 2018 11:00 AM IST
    MUMBAI: Two ayurvedic drugs meant to increase sexual desire and potency randomly tested for quality by Aurangabad division of FDA has found containing...
    Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

    Jiva Ayurveda launches first-ever diagnostic protocols for Ayurveda

    Ruby Khatun Khatun20 July 2018 10:00 AM IST
    New Delhi: Jiva Ayurveda, a leading and trusted name in Ayurveda, launched first-of-its-kind diagnostic protocols for Ayurveda with the aim to create...
    No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

    No clinical trials need for Ayurveda, Unani, Siddha Medicines: Government of India

    Ruby Khatun Khatun11 July 2018 4:26 PM IST
    New Delhi: Through a recent notification, the Government of India has clarified that no clinical trials are required for issuing licenses patented or...
    Boiron launches pre-medicated homeopathic medicines in India

    Boiron launches pre-medicated homeopathic medicines in India

    Ruby Khatun Khatun3 July 2018 10:15 AM IST
    New Delhi: Boiron India, subsidiary of Boiron France, has launched pre-medicated standardized homeopathic medicines for the first time in the...
    India for formal recognition of traditional medicines in Singapore

    India for formal recognition of traditional medicines in Singapore

    Ruby Khatun Khatun23 Jun 2018 10:00 AM IST
    Singapore: India is working towards formal recognition of traditional Indian medicines and practices in Singapore where there is a huge market, the...
    MSME, AYUSH ministries to develop traditional medicine enterprises

    MSME, AYUSH ministries to develop traditional medicine enterprises

    Ruby Khatun Khatun7 Jun 2018 10:00 AM IST
    New Delhi: Ministries of MSME and AYUSH joined hands for developing enterprises in the traditional medicine sector."The memorandum of understanding...
    Cabinet approves MoU between India, Equatorial Guinea in medicine

    Cabinet approves MoU between India, Equatorial Guinea in medicine

    Ruby Khatun Khatun18 May 2018 10:15 AM IST
    New Delhi: The Union Cabinet chaired by Prime Minister Narendra Modi on Wednesday gave its ex-post facto approval to the Memorandum of Understanding...
    Monitoring, regulating misleading ads for promoting Ayush medicine sale vital: Report

    Monitoring, regulating misleading ads for promoting Ayush medicine sale vital: Report

    Ruby Khatun Khatun30 April 2018 10:00 AM IST
    New Delhi: It is the need of the hour to strictly monitor and regulate the misleading advertisements for promoting the sale of Ayush medicine, a...
    Cabinet approves MoU between India, African nation in medicinal plants sector

    Cabinet approves MoU between India, African nation in medicinal plants sector

    Ruby Khatun Khatun26 April 2018 10:15 AM IST
    New Delhi: The government gave an ex-post facto approval for an agreement signed between India and an African island nation, Sao Tome and Principe, to...
    Ayush Drug Advertising Regulation- ASCI now part of regulatory committee

    Ayush Drug Advertising Regulation- ASCI now part of regulatory committee

    Ruby Khatun Khatun19 April 2018 10:30 AM IST
    Mumbai: Advertising sector watchdog ASCI said it is part of the ministry of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy...
    PrevNext

    Popular Stories

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Aurobindo Pharma faces CA Suit in US for concealing facts

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    Cygnus Medicare sells majority stake to Amar Ujala for Rs 130 crore

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    AstraZeneca gets USFDA nod for Koselugo for paediatric patients with neurofibromatosis type 1

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok